To assess the positive Impact of a nutraceutical (GLUBLOC™ granules) on postprandial blood glucose levels when taken along with the carbohydrate rich meal

A Prospective, Randomised, Placebo Controlled Study to Evaluate the Impact of GLUBLOC™ on postprandial blood glucose levels in healthy individuals post carbohydrate rich meal intake. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061799

Enrollment

100

Registered

2024-01-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: GLUBLOC™ Granules (STUDY 1): A proprietary blend of Morus alba L and Malus domestica peel extracts - 350 mg, proprietary blend of Morus alba L extract and Malus domestica peel extract

Eligibility

Inclusion criteria

Inclusion criteria: Aged between 18 to 60 years BMI between 18.5 and 29.9 kg per m2 Fasting blood glucose greater than 70 mg per dl and less than or equal to 99 mg per dl

Exclusion criteria

Exclusion criteria: History of hypersensitivity to any of the investigational product, excipients, or Any known food allergies. Pre-existing medical condition or taking medication known to affect glucose regulation or influence digestion and absorption of nutrients History of diabetes mellitus (type I or II) or they used antihyperglycemic drugs or insulin to treat diabetes or related conditions Used steroids, protease inhibitors or antipsychotic medicines as these drugs are known to impact glucose metabolism and body fat distribution. Subjects with the history of uncontrolled hypertension or hyperthyroidism. History of alcoholism Subjects with psychiatric or neurological disability or mental health disorder Subjects with serious health conditions such as cardiac disease, renal dysfunction, and cancers. Subjects who donot have basic understanding of English language, which include speaking or writing in English. Female subjects who are pregnant or had planned for pregnancy in the following months or were breast feeding. Subjects who refuse to sign informed consent. According to the investigators opinion, participants who are deemed unable to comply with the test requirements or otherwise deemed unsuitable.

Design outcomes

Primary

Measure	Time frame
To assess the impact of Glubloc™ granules on postprandial changes in blood glucose levels post carbohydrate rich meal intake.Timepoint: Time points: t0 (fasting), t30, t60, t90 and t120 minutes on Day 1 & Day 5.	—

Secondary

Measure	Time frame
Observation of Adverse events during the study periodTimepoint: Day 1 & Day 5	—

Countries

India

Contacts

Public ContactDr Chaitanya Gali

My PuraVida Wellness Pvt Ltd

chaitanya@formen.co.in9391752535

Outcome results